KNOTUS Co.Ltd Cash Flow Conversion Efficiency
KNOTUS Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, KNOTUS Co.Ltd (278650) has a cash flow conversion efficiency ratio of -0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-9.34 Billion ≈ $-6.33 Million USD) by net assets (₩112.17 Billion ≈ $76.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of KNOTUS Co.Ltd (2016–2024)
Cash flow conversion efficiency of KNOTUS Co.Ltd from 2016 to 2024. This chart illustrates how KNOTUS Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest KNOTUS Co.Ltd stock price today for real-time trading data and today's change.
KNOTUS Co.Ltd Cash Flow Conversion Ratio Explained
KNOTUS Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
KNOTUS Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of KNOTUS Co.Ltd ranked by their cash flow conversion efficiency. Also see KNOTUS Co.Ltd (278650) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Green Cross
KO:005250
|
0.074x |
|
Syncmold Enterprise Corp
TW:1582
|
0.036x |
|
Afrimat
JSE:AFT
|
0.117x |
|
BLS E-Services Limited
NSE:BLSE
|
0.018x |
|
Metrodata Electronics Tbk
JK:MTDL
|
-0.162x |
|
Vaibhav Global Limited
NSE:VAIBHAVGBL
|
0.041x |
|
Kitex Garments Limited
NSE:KITEX
|
0.174x |
|
Nanjing Chixia Development Co Ltd
SHG:600533
|
0.003x |
Annual Cash Flow Conversion Efficiency for KNOTUS Co.Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of KNOTUS Co.Ltd from 2016 to 2024. Review free cash flow generation of KNOTUS Co.Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩111.87 Billion ≈ $75.82 Million |
₩-11.67 Billion ≈ $-7.91 Million |
-0.104x | -308.10% |
| 2023-12-31 | ₩103.57 Billion ≈ $70.19 Million |
₩5.19 Billion ≈ $3.52 Million |
0.050x | -45.64% |
| 2022-12-31 | ₩70.28 Billion ≈ $47.63 Million |
₩6.48 Billion ≈ $4.39 Million |
0.092x | -29.62% |
| 2021-12-31 | ₩64.59 Billion ≈ $43.77 Million |
₩8.46 Billion ≈ $5.74 Million |
0.131x | -38.68% |
| 2020-12-31 | ₩53.64 Billion ≈ $36.35 Million |
₩11.46 Billion ≈ $7.77 Million |
0.214x | +72.64% |
| 2019-12-31 | ₩41.86 Billion ≈ $28.37 Million |
₩5.18 Billion ≈ $3.51 Million |
0.124x | -50.63% |
| 2018-12-31 | ₩20.67 Billion ≈ $14.01 Million |
₩5.18 Billion ≈ $3.51 Million |
0.251x | -22.38% |
| 2017-12-31 | ₩16.04 Billion ≈ $10.87 Million |
₩5.18 Billion ≈ $3.51 Million |
0.323x | -13.89% |
| 2016-12-31 | ₩8.36 Billion ≈ $5.66 Million |
₩3.13 Billion ≈ $2.12 Million |
0.375x | -- |
About KNOTUS Co.Ltd
HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug deve… Read more